These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35523947)

  • 21. G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses.
    Zhu QS; Robinson LJ; Roginskaya V; Corey SJ
    Blood; 2004 May; 103(9):3305-12. PubMed ID: 14656892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma.
    Chiu DK; Tse AP; Xu IM; Di Cui J; Lai RK; Li LL; Koh HY; Tsang FH; Wei LL; Wong CM; Ng IO; Wong CC
    Nat Commun; 2017 Sep; 8(1):517. PubMed ID: 28894087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2.
    Dorsey JF; Cunnick JM; Mane SM; Wu J
    Blood; 2002 Feb; 99(4):1388-97. PubMed ID: 11830491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy.
    Parker KH; Horn LA; Ostrand-Rosenberg S
    J Leukoc Biol; 2016 Sep; 100(3):463-70. PubMed ID: 26864266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease.
    Hundertmark J; Krenkel O; Tacke F
    Front Immunol; 2018; 9():2418. PubMed ID: 30405618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effects of SHP2 and PI3K pathway inhibitors in GAB2-overexpressing ovarian cancer.
    Sun B; Jensen NR; Chung D; Yang M; LaRue AC; Cheung HW; Wang Q
    Am J Cancer Res; 2019; 9(1):145-159. PubMed ID: 30755818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
    Hetta HF; Zahran AM; Mansor SG; Abdel-Malek MO; Mekky MA; Abbas WA
    J Med Virol; 2019 Jul; 91(7):1319-1328. PubMed ID: 30761547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR2 limits development of hepatocellular carcinoma by reducing IL18-mediated immunosuppression.
    Li S; Sun R; Chen Y; Wei H; Tian Z
    Cancer Res; 2015 Mar; 75(6):986-95. PubMed ID: 25600646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA snaR upregulates GRB2-associated binding protein 2 and promotes proliferation of ovarian carcinoma cells.
    Huang Y; Hu Y; Jin Z; Shen Z
    Biochem Biophys Res Commun; 2018 Sep; 503(3):2028-2032. PubMed ID: 30093110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-197 inhibits cell proliferation by targeting GAB2 in glioblastoma.
    Tian LQ; Liu EQ; Zhu XD; Wang XG; Li J; Xu GM
    Mol Med Rep; 2016 May; 13(5):4279-88. PubMed ID: 27035789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid cells in hepatocellular carcinoma.
    Wan S; Kuo N; Kryczek I; Zou W; Welling TH
    Hepatology; 2015 Oct; 62(4):1304-12. PubMed ID: 25914264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Low Doses of 5-Fluorouracil Diminishes Immunosuppression by Myeloid Derived Suppressor Cells in Murine Melanoma Model.
    Namdar A; Mirzaei HR; Jadidi-Niaragh F; Ashourpour M; Ajami M; Hadjati J; Rezaei A
    Iran J Immunol; 2015 Sep; 12(3):176-87. PubMed ID: 26412636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3.
    Xu Y; Huang Y; Xu W; Zheng X; Yi X; Huang L; Wang Y; Wu K
    Onco Targets Ther; 2020; 13():1497-1505. PubMed ID: 32110047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations.
    Liu W; Yu WM; Zhang J; Chan RJ; Loh ML; Zhang Z; Bunting KD; Qu CK
    Leukemia; 2017 Jun; 31(6):1415-1422. PubMed ID: 27840422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes.
    Wang Y; Zhang T; Sun M; Ji X; Xie M; Huang W; Xia L
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activation.
    Herrera Abreu MT; Hughes WE; Mele K; Lyons RJ; Rickwood D; Browne BC; Bennett HL; Vallotton P; Brummer T; Daly RJ
    Mol Biol Cell; 2011 Jan; 22(1):105-16. PubMed ID: 21118992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1.
    Gu S; Chan WW; Mohi G; Rosenbaum J; Sayad A; Lu Z; Virtanen C; Li S; Neel BG; Van Etten RA
    Blood; 2016 Apr; 127(14):1803-13. PubMed ID: 26773044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Down-Regulation of SUZ12 Accelerates the Migration and Invasion of Liver Cancer Cells via Activating ERK1/2 Pathway.
    Xue C; Wang K; Jiang X; Gu C; Yu G; Zhong Y; Liu S; Nie Y; Zhou Y; Yang H
    J Cancer; 2019; 10(6):1375-1384. PubMed ID: 31031847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.